The role of CD40L in resistance to enteric infection

NIH RePORTER · NIH · U01 · $552,706 · view on reporter.nih.gov ↗

Abstract

Project Summary The ability of recently activated T cells to express the cell surface molecule CD40L allows them to communicate with other immune and non-immune populations. This molecule is of particular importance in the gut to help control the parasitic infection caused by Cryptosporidium. Here we leverage a novel, natural mouse model of Cryptosporidium to dissect the impact of the CD40-CD40L interaction in T cell-mediated resistance to infection in the gut. In this model, WT mice (like humans) develop sterile immunity mediated by T cell production of IFN-γ, but mice that lack CD40L mice (like humans) do not resolve infection. In addition, treatment of chronically infected CD40L-deficient mice with soluble (s)CD40L results in rapid parasite clearance. We will test if protective effect of CD40L may be explained by either I. its ability to promote T cell responses essential for resistance and/or II. because CD40L directly activates EC to limit parasite growth. We are uniquely equipped to utilize parasite transgenesis, combined with sophisticated genetic approaches to define the key cellular interactions that allows CD40L to determine the outcome of an enteric infection.

Key facts

NIH application ID
10470882
Project number
5U01AI163671-02
Recipient
UNIVERSITY OF PENNSYLVANIA
Principal Investigator
CHRISTOPHER A HUNTER
Activity code
U01
Funding institute
NIH
Fiscal year
2022
Award amount
$552,706
Award type
5
Project period
2021-08-17 → 2026-05-31